H.R. 2503 · 115th Congress

Accelerating Innovation in Medicine Act of 2017

Stage
In committee
Introduced
2017-05-17
Latest action
2017-05-30 · Referred to the Subcommittee on Health.

Summary

Accelerating Innovation in Medicine Act of 2017 or the AIM Act of 2017

This bill requires the Centers for Medicare & Medicaid Services (CMS) to develop, maintain, and make publicly available a list of medical devices that shall be voluntarily excluded from payment under the Medicare program. A Medicare beneficiary who consents to receive such a medical device shall be responsible for payment for the device.

A manufacturer seeking to have a medical device included in the list must submit a request for inclusion to the CMS, in accordance with specified timelines. As a condition for a device's continued inclusion on the list, a manufacturer must provide the CMS with data on clinical studies completed with respect to the device.